Provided by Tiger Trade Technology Pte. Ltd.

Qiagen NV

44.38
+1.483.45%
Pre-market: 44.660.2800+0.63%06:01 EDT
Volume:1.91M
Turnover:84.49M
Market Cap:9.14B
PE:22.57
High:44.57
Open:43.79
Low:43.65
Close:42.90
52wk High:57.82
52wk Low:32.53
Shares:206.00M
Float Shares:205.74M
Volume Ratio:1.26
T/O Rate:0.93%
Dividend:0.36
Dividend Rate:0.82%
EPS(TTM):1.97
EPS(LYR):2.04
ROE:11.93%
ROA:5.87%
PB:2.72
PE(LYR):21.73

Loading ...

Qiagen Supports Infectious Disease Research And Surveillance Efforts For Bundibugyo Ebolavirus Outbreak

Reuters
·
May 29

Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK) and Qiagen (QGEN)

TIPRANKS
·
May 28

Assessing Qiagen (NYSE:QGEN) Valuation After New AI Assistant Launch And Expanded NVIDIA Collaboration

Simply Wall St.
·
May 24

Qiagen Faces Legal Review As QuantiFERON Outlook Shifts And Valuation Draws Focus

Simply Wall St.
·
May 20

Qiagen's Digital Insights Business to Integrate Nvidia's BioNeMo Platform

MT Newswires Live
·
May 20

Qiagen Digital Insights to integrate Nvidia accelerated computing

TIPRANKS
·
May 20

Qiagen partners with Nvidia on graph-based AI drug discovery platform integration

Reuters
·
May 20

Analysts Conflicted on These Healthcare Names: Qiagen (QGEN), SAB Biotherapeutics (SABS) and Moderna (MRNA)

TIPRANKS
·
May 14

Qiagen Is Maintained at Hold by TD Cowen

Dow Jones
·
May 08

Qiagen NV reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 07

Analysts Conflicted on These Healthcare Names: ACADIA Pharmaceuticals (ACAD), Qiagen (QGEN) and Alcon (ALC)

TIPRANKS
·
May 07

Qiagen Q1 Adj. EPS $0.54, Inline, Sales $492.000M Miss $498.031M Estimate

Benzinga Earnings
·
May 07

Press Release: QIAGEN Reports Full Results for Q1 2026

Dow Jones
·
May 07

Qiagen NV expected to post earnings of 54 cents a share - Earnings Preview

Reuters
·
May 05

Qiagen (QGEN) Gets a Buy from DZ BANK AG

TIPRANKS
·
Apr 30

Earning Preview: Qiagen NV this quarter’s revenue is expected to increase by 6.58%, and institutional views are bullish

Earnings Agent
·
Apr 29

Baird Upgrades QIAGEN to Outperform From Neutral, Cuts Price Target to $43 From $53

MT Newswires Live
·
Apr 29

Qiagen Raised to Outperform From Neutral by Baird

Dow Jones
·
Apr 29

QIAGEN Down Over 10%, on Track for Lowest Close Since November 2019 -- Data Talk

Dow Jones
·
Apr 28

Analysts Offer Insights on Healthcare Companies: Qiagen (QGEN), Eli Lilly & Co (LLY) and Janux Therapeutics Inc (JANX)

TIPRANKS
·
Apr 28